Next Article in Journal
Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B
Previous Article in Journal
7,8-Dihydroxy Efavirenz Is Not as Effective in CYP46A1 Activation In Vivo as Efavirenz or Its 8,14-Dihydroxy Metabolite
Previous Article in Special Issue
Behçet’s Disease: A Comprehensive Review on the Role of HLA-B*51, Antigen Presentation, and Inflammatory Cascade
 
 
Review

Article Versions Notes

Int. J. Mol. Sci. 2024, 25(4), 2243; https://doi.org/10.3390/ijms25042243
Action Date Notes Link
article pdf uploaded. 13 February 2024 13:16 CET Version of Record https://www.mdpi.com/1422-0067/25/4/2243/pdf-vor
article xml file uploaded 18 February 2024 11:12 CET Original file -
article xml uploaded. 18 February 2024 11:12 CET Update https://www.mdpi.com/1422-0067/25/4/2243/xml
article pdf uploaded. 18 February 2024 11:12 CET Updated version of record https://www.mdpi.com/1422-0067/25/4/2243/pdf
article html file updated 18 February 2024 11:13 CET Original file https://www.mdpi.com/1422-0067/25/4/2243/html
Back to TopTop